Form 8-K - Current report:
SEC Accession No. 0001789769-21-000029
Filing Date
2021-05-13
Accepted
2021-05-13 16:40:50
Documents
3
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K instilbio-8xkq1x21.htm 8-K 31823
2 EX-99.1 q1-21earningspressrelease.htm EX-99.1 37553
3 LOGO image_01.jpg GRAPHIC 42220
  Complete submission text file 0001789769-21-000029.txt   128779
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 21920271
SIC: 2836 Biological Products, (No Diagnostic Substances)